GoatVac C.D.-T

This page contains information on GoatVac C.D.-T for veterinary use.
The information provided typically includes the following:
  • GoatVac C.D.-T Indications
  • Warnings and cautions for GoatVac C.D.-T
  • Direction and dosage information for GoatVac C.D.-T

GoatVac C.D.-T

This treatment applies to the following species:
Manufacturer: Durvet

Clostridium Perfringens Types C & D-Tetanus Toxoid

For use in healthy goats as an aid in the prevention of enterotoxemia caused by Clostridium Perfringens types B, C and D. Cl. Perfringens Type B is not a significant problem in North America.

For the long term protection against tetanus.

Contains thimerosal as a preservative.

Directions For Use

Do not vaccinate within 21 days before slaughter. Shake well before use. Use entire contents when first opened. Store at 2° to 7° C. Do not freeze.

Precautions

Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent.

Dosage and Administration

Inject 2 ml. subcutaneously or intramuscularly. Repeat full dose in 3 to 4 weeks.

FOR VETERINARY USE ONLY

USDA Code No: 8304.00

Manufactured by: Colorado Serum Company, 4950 York St., Denver, CO. 80216

U.S. Vet License No. 188

Manufactured for: Durvet, Inc, 100 S.E. Magellan Drive, Blue Springs, MO. 64014

10 Doses

20 ml.

Iss: 5/04

NAC No.: 10842540

DURVET, INC.
P.O. BOX 279, 100 S.E. MAGELLAN DRIVE, BLUE SPRINGS, MO, 64014
Telephone:   816-229-9101
Toll-Free:   800-821-5570
Fax:   816-224-3080
Website:   www.durvet.com
Email:   info@durvet.com
Every effort has been made to ensure the accuracy of the GoatVac C.D.-T information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-12-03

(web1)